SPDR SP Ownership
| XBI Etf | USD 98.85 1.22 1.25% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
SPDR |
SPDR Etf Ownership Analysis
SPDR SP is is formed as Regulated Investment Company in the United States. ETF is managed and operated by SSgA Funds Management, Inc.. The fund has 168 constituents with avarage daily trading value of 10.6 M. The fund charges 0.35 percent management fee with a total expences of 0.35 percent of total asset. The fund keeps 99.97% of net assets in stocks. SPDR SP Biotech last dividend was 0.017 per share. In seeking to track the performance of the SP Biotechnology Select Industry Index , the fund employs a sampling strategy. SP Biotech is traded on NYSEARCA Exchange in the United States. For more information please call the company at NA.Sector Exposure (%)
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on SPDR Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding SPDR SP , and the less return is expected.
Investment Allocations (%)
Top Etf Constituents
| MGNX | MacroGenics | Stock | |
| LGND | Ligand Pharmaceuticals Incorporated | Stock | |
| BMRN | Biomarin Pharmaceutical | Stock | |
| NBIX | Neurocrine Biosciences | Stock | |
| EDIT | Editas Medicine | Stock | |
| INO | Inovio Pharmaceuticals | Stock | |
| AGIO | Agios Pharm | Stock | |
| CLVS | Clovis Oncology | Stock | |
| NVAX | Novavax | Stock | |
| HGEN | Humanigen | Stock | |
| MDXG | MiMedx Group | Stock | |
| ESPR | Esperion Therapeutics | Stock | |
| OCGN | Ocugen Inc | Stock | |
| FOLD | Amicus Therapeutics | Stock | |
| AVXL | Anavex Life Sciences | Stock | |
| UTHR | United Therapeutics | Stock | |
| HRTX | Heron Therapeuti | Stock | |
| ANAB | AnaptysBio | Stock | |
| BPMC | Blueprint Medicines Corp | Stock | |
| VKTX | Viking Therapeutics | Stock | |
| RARE | Ultragenyx | Stock | |
| BEAM | Beam Therapeutics | Stock | |
| ALKS | Alkermes Plc | Stock | |
| TBIO | Telesis Bio | Pink Sheet | |
| APLS | Apellis Pharmaceuticals | Stock |
Institutional Etf Holders for SPDR SP
| BUYW | Main Buywrite ETF | Etf | |
| DEVDX | Driehaus Event Driven | Mutual Fund | |
| TCMSX | Tcm Small Cap | Mutual Fund | |
| CAPTX | Canterbury Portfolio Thermostat | Mutual Fund | |
| FIMPX | Nuveen Small Cap | Mutual Fund | |
| FRMPX | Nuveen Small Cap | Mutual Fund | |
| FMPFX | Nuveen Small Cap | Mutual Fund | |
| ETFCX | Stadion Tactical Growth | Mutual Fund | |
| ETFAX | Stadion Tactical Growth | Mutual Fund | |
| SECT | Main Sector Rotation | Etf | |
| TSCGX | Thrivent Small Cap | Mutual Fund | |
| HHCAX | Highland Longshort Healthcare | Mutual Fund | |
| HHCCX | Highland Longshort Healthcare | Mutual Fund | |
| HHCZX | Highland Longshort Healthcare | Mutual Fund | |
| LABU | Direxion Daily SP | Etf |
SPDR SP's latest congressional trading
Congressional trading in companies like SPDR SP Biotech, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in SPDR SP by those in governmental positions are based on the same information available to the general public.
| 2024-08-06 | Representative David P Joyce | Acquired $15K to $50K | Verify | ||
| 2024-06-13 | Senator Tommy Tuberville | Acquired Under $15K | Verify |
SPDR SP Outstanding Bonds
SPDR SP issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SPDR SP Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SPDR bonds can be classified according to their maturity, which is the date when SPDR SP Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US7846ELAD98 Corp BondUS7846ELAD98 | View | |
| SSC Technologies 55 Corp BondUS78466CAC01 | View | |
| US7846ELAE71 Corp BondUS7846ELAE71 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Currently Active Assets on Macroaxis
When determining whether SPDR SP Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Biotech Etf:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
The market value of SPDR SP Biotech is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.